Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Leucine + glycerol is a combination used in parenteral nutrition, most notably as the product ProcalAmine. This formulation provides essential and nonessential amino acids (including leucine) alongside glycerol as a non-protein energy source. Leucine is an essential branched-chain amino acid that supports protein synthesis, muscle mass preservation, nitrogen balance, and metabolic regulation by activating the mTOR pathway. Glycerol serves as an energy substrate; it is metabolized primarily in the liver for gluconeogenesis and energy production via conversion to dihydroxyacetone phosphate. The combination aims to preserve body protein and improve nitrogen balance in patients requiring short-term parenteral nutrition who are mildly catabolic but otherwise well-nourished[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on leucine + glycerol.